After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...
The Chosun Ilbo on MSN
Immune checkpoint inhibitors revolutionize cancer treatment
Mr. Kim, 62 years old, a man preparing for retirement, was an office worker diligently attending to his job just a year ago.
A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...
ICIs combined with chemotherapy showed higher efficacy than bevacizumab in treating advanced driver gene–negative NS-NSCLC. The study reported improved PFS and OS for patients receiving ICIs compared ...
The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized oncology. However, a significant proportion of patients ...
Morning Overview on MSN
Study maps prostate immune niches, finds T cells linger for months
Prostate cancer has long frustrated immunologists. Checkpoint inhibitors that unleash the immune system against tumors in the ...
Immune system activation and activity is regulated through stimulatory or inhibitory ligand-receptor interactions collectively termed immune checkpoints. 1 Stimulatory interactions give the immune ...
Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results